ROADMAP FOR BIOTECH

                  Every day, we use our homegrown technologies to discover, develop, research and deliver new medicines that help people with serious diseases. Watch to see what drives us.

                  Regeneron (NASDAQ: REGN) is a leading biotechnology company that invents life-transforming medicines for people with serious diseases. Founded and led for 30 years by physician-scientists, our unique ability to repeatedly and consistently translate science into medicine has led to seven FDA-approved treatments and numerous product candidates in development, all of which were homegrown in our laboratories. Our medicines and pipeline are designed to help patients with eye disease, allergic and inflammatory diseases, cancer, cardiovascular and metabolic diseases, infectious diseases, pain and rare diseases.

                  Regeneron is accelerating and improving the traditional drug development process through our proprietary VelociSuite? technologies, such as VelocImmune? which produces optimized fully-human antibodies, and ambitious research initiatives such as the Regeneron Genetics Center, which is conducting one of the largest genetics sequencing efforts in the world.

                  FOR 30 YEARS, OUR
                  MISSION HAS BEEN TO
                  USE THE POWER OF
                  SCIENCE TO BRING
                  NEW MEDICINES TO
                  PATIENTS... OVER
                  AND OVER AGAIN.

                  Neil Stahl, PhD, Executive VP,
                  Research and Development

                  2018 annual report PDF download

                  Check out our 2018 annual materials. The Responsibility Report and Annual Report are now online.

                  Read our annual report
                  and responsibility report

                  2018 responsibility report PDF download

                  REGENERON BY THE NUMBERS

                  • 30
                    years of scientific
                  • 8,100+
                  • 700+
                    employees with
                    an MD, PhD or
                    PharmD degree
                  • 6TH
                    consecutive year
                    in Forbes’ World’s
                    Most Innovative
                  • #1
                    ranking in Science
                    magazine’s global Top
                    Employer survey for six
                    of the past nine years
                  • 31,000+
                    employee volunteer hours
                    for 100+ organizations
                    in 2018
                  • 7
                  • 98%
                    of our waste
                    diverted from
                    landfill, surpassing
                    our goal
                  • 100%
                    of drug candidates
                    invented and
                    developed in-house
                  • 800,000+
                    exomes sequenced
                    to date
                  • 100+
                    publications in 2018
                  • 20+
                    product candidates in
                    clinical development
                    across multiple
                    therapeutic areas
                  • Newsweek, America’s Most Responsible Companies, 2020

                    IDEA Pharma, Pharmaceutical Invention Index, 2019

                    RobecoSAM and S&P Dow Jones Indices: Dow Jones Sustainability World Index, 2019

                    Science: Top Employer, 2019

                    Harvard Business Review: Best Performing CEOs, 2019

                    Civic 50: Most Community-Minded Companies in the Nation, 2019

                  • Fast Company: Best Workplaces for Innovators, 2019

                    Shingo Institute: The Shingo Prize, 2019

                    Great Places to Work: Best Workplace in Ireland, 2019

                    Forbes: Top 10 Most Innovative Companies, 2018

                    Fortune: Best Companies to Work for, 2018


                  We are the only biopharmaceutical company to be led by physician-scientists for more than 30 years. We consistently demonstrate our commitment to scientific excellence by counting multiple Nobel Laureates and five members of the National Academy of Sciences among our leadership, as well as being one of the first companies to form a Science and Technology Committee as an integral component of its Board, a practice which has since become industry standard.

                  Our leadership

                  A FOCUS
                  ON SCIENCE

                  From our first days, science has remained our central guiding principle.

                  Our journey